Ocugen (OCGN) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $12.00 price target on the stock.
Why Ocugen (OCGN) Is Up 54.0% After OCU400 Phase 3 Progress And Going Concern Spotlight [Yahoo! Finance]
How Ocugen (OCGN) Phase 2 And Phase 3 Milestones Are Reframing The Investment Story [Yahoo! Finance]
Ocugen spikes as Oppenheimer issues new Outperform on upcoming catalysts [Seeking Alpha]
Oppenheimer Starts Ocugen (OCGN) at Outperform on Gene Therapy Pipeline [Yahoo! Finance]